Veracyte (VCYT) Tops Q2 EPS by 33c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Veracyte, Inc (VCYT) PT Lowered to $28 at Morgan Stanley
August 8, 2025 2:49 PM EDTMorgan Stanley analyst Tejas Savant lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $28.00 (from $29.00) while maintaining a Underweight rating.
The analyst comments "Solid 2Q beat on continued Decipher/Afirma momentum leading to '25 guidance raise; total company guidance now initiated following Veracyte SAS... More
